Status:
RECRUITING
Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism
Lead Sponsor:
Aarhus University Hospital
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or compl...
Detailed Description
Purpose The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) ...
Eligibility Criteria
Inclusion
- Age\>18 years and able to give informed consent.
- Suspicion or diagnosis of thyroid cancer.
- Planned total thyroidectomy or completion thyroidectomy.
- Normocalcemia prior to surgery.
Exclusion
- Planned simultaneous parathyroid surgery.
- Treatment with active vitamin D analogues.
- eGFR \< 30.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06222606
Start Date
January 1 2024
End Date
January 1 2027
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Denmark, Denmark, 8200